The Bronchodilator Drugs market in Central America is anticipated to witness a significant growth in revenue, with projections indicating that it will reach US$46.90m by 2024. Moreover ...

The Bronchodilator Drugs market in South Korea is forecasted to achieve a revenue of US$0.37bn in 2024. It is expected to exhibit a compound annual growth rate (CAGR) of 3.99% from 2024 to 2029 ...

Clenbuterol has not been approved by the U.S. Food and Drug Administration (FDA) as an ingredient for any drugs for humans, ...

A new study reveals that ensifentrine, a novel COPD treatment, significantly reduces COPD-related healthcare usage over 48 ...

The FDA announced on Thursday a proposed order to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) ...

Today, the U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter (OTC) monograph drug products for the ...

Are you searching for medications to treat 'Asthma'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Asthma. The page includes both the ...

Are you searching for medications to treat 'Respiratory Diseases'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Respiratory Diseases. The ...

Bronchodilator therapy forms the mainstay of ... in respiratory diseases – spanning almost 100 years of innovation in drug and device development – there is continuing medical need for ...

Cholinergic drugs (acetylcholine and methacholine ... Tiotropium, the first-choice long-acting bronchodilator in COPD, has been studied in severe asthmatics and in COPD patients with a history ...

Rubaab, an 8-year-old Noida student living in Delhi, has been using a nebuliser ever since he was a toddler. A nebulizer is a ...